GENOTYPE/PHENOTYPE STUDIES IN HYPERTROPHIC CARDIOMYOPATHY
GENOTYPE/PHENOTYPE STUDIES IN HYPERTROPHIC CARDIOMYOPATHY
批准号:
3843410
负责人:
L FANANAPAZIR
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
肥厚型心肌病是最常见的遗传性心脏病
疾病。最近,β肌球蛋白重链(BetaMHC)基因已经
在大约一半的家庭中,与母婴传播疾病有关联。我们之前已经
报告说,BetaMHC基因的两个明显突变明显
不同的临床表现和预后:908Leu=>;Val突变
在270名肥厚型心肌病(HCM)成员中,有亲属关系
猝死(SD)发生率低,疾病外显率为61%。
然而,在一个19人(高加索人)家族中,403Arg=>;Gln突变是
与SD的高发病率和100%的疾病外显率有关。
最近,一个606Val=>;Met突变与“接近正常生存”有关
在3个小家庭中被报告并被提供作为证据
中性电荷替换的良性性质。我们报告1)a)
606Val=>;与4个受影响成员中出现的SD和2)a)相匹配
第二个(东方)家系,403Arg=>;Gln突变。虽然
403Arg=>;Gln在两个家族中都是严重的和早期的疾病
突变、心脏形态和血流动力学特征明显。合而为一
所有患者均为非梗阻性肥厚型心肌病,并有左室舒张功能。
在另一家系中,所有患者均有梗阻性肥厚心肌。
因此,1)必须使用大家族来判断突变是良性的,2)
蛋氨酸突变在某些家族中是恶性的,因此是轻微的
BetaMHC蛋白关键区域的替换也可能具有
严重的后果,以及3)两个403人的不同种族来源
血缘关系证明相同的突变是独立发生的
有两种不同的遗传背景。他们相似但又截然不同
表型强调了修饰基因的重要性。
英文摘要
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac
disease. Recently, the betaeta myosin heavy chain (betaMHC) gene has
been linked with HCM in about half of the kindreds. We have previously
reported that two distinct mutations in the betaMHC gene had markedly
different clinical presentations and prognoses: The 908Leu=>Val mutation
in a 270 member hypertrophic cardiomyopathy (HCM) kindred was associated
with a low incidence of sudden death (SD) and a 61% disease penetrance.
The 403Arg=>Gln mutation however, in a 19-member (caucasian) kindred was
associated with a high incidence of SD and 100% disease penetrance.
Recently, a 606Val=>Met mutation, associated with "near normal survival"
in 3 small kindreds has been reported and offered as evidence for the
benign nature of neutral charge substitutions. We report 1) a
606Val=>Met kindred with 4 SD occurring in - affected members and 2) a
second (oriental) kindred with the 403Arg=>Gln mutation. Although
disease was severe and early in both kindreds with the 403Arg=>Gln
mutation, cardiac morphology and hemodynamics were distinct. In one
kindred all patients had non-obstructive HCM and LV diastolic
dysfunction while in the other kindred all patients had obstructive HCM.
Thus, 1) large kindreds must be used to judge a mutation benign, 2)
606Val=>Met mutation is malignant in some kindreds and hence minor
substitutions in critical regions of betaMHC protein may also have
serious consequences, and 3) the diverse ethnic origins of the two 403
kindreds is proof that the identical mutation had occurred independently
on two different genetic backgrounds. Their similar yet distinct
phenotype underlines the importance of modifying genes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PREDICTION OF ADVERSE EFFECTS OF AMIODARONE BY SIGNAL AVERAGING IN HCM PATIENTS
-
批准号:3920190
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:L FANANAPAZIR
-
依托单位:
INDUCTION OF MALIGNANT VENTRICULAR TACHYCARDIA ON AMIODARONE IN HCM PATIENTS
-
批准号:3920192
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:L FANANAPAZIR
-
依托单位:
CENTRAL CORE DISEASE IN HYPERTROPHIC CARDIOMYOPATHY
-
批准号:3843406
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:L FANANAPAZIR
-
依托单位:
INHERITED CARDIAC DISEASES--HYPERTROPHIC CARDIOMYOPATHY
-
批准号:3757734
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:L FANANAPAZIR
-
依托单位:
MANAGEMENT OF MALIGNANT VENTRICULAR ARRHYTHMIA IN PATIENTS WITH IHSS
-
批准号:3916506
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:L FANANAPAZIR
-
依托单位:
MANAGEMENT OF SYMPTOMS AND ARRHYTHMIAS IN HYPERTROPHIC CARDIOMYOPATHY
-
批准号:3858130
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:L FANANAPAZIR
-
依托单位:
PROGRAMMED STIMULATION FINDINGS IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
-
批准号:3920187
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:L FANANAPAZIR
-
依托单位:
ABNORMAL MYOSIN IN-VITRO MOTILITY ACTIVITY IN HYPERTROPHIC CARDIOMYOPATHY
-
批准号:3843405
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:L FANANAPAZIR
-
依托单位:
PROGNOSTIC DETERMINANTS IN HYPERTROPHIC CARDIOMYOPATHY
-
批准号:3843411
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:L FANANAPAZIR
-
依托单位:
MANAGEMENT OF MALIGNANT VENTRICULAR ARRHYTHMIA IN PATIENTS WITH IHSS
-
批准号:3837966
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:L FANANAPAZIR
-
依托单位:
SKELETAL MYOFIBER TENSION IN HYPERTROPHIC CARDIOLOGY
-
批准号:3843407
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:L FANANAPAZIR
-
依托单位:
CORRELATION OF SIGNAL AVERAGING WITH PROGRAMMED STIMULATION IN HCM PATIENTS
-
批准号:3920188
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:L FANANAPAZIR
-
依托单位:
ARRHYTHMIAS IN HYPERTROPHIC CARDIOMYOPATHY
-
批准号:3879051
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:L FANANAPAZIR
-
依托单位:
PROGNOSIS AND ELECTROPHYSIOLOGIC FUNDINGS IN HCM SUDDEN CARDIAC DEATH SURVIVORS
-
批准号:3920191
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:L FANANAPAZIR
-
依托单位:
MANAGEMENT OF MALIGNANT VENTRICULAR ARRHYTHMIA IN PATIENTS WITH IHSS
-
批准号:3874325
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:L FANANAPAZIR
-
依托单位:
DUAL CHAMBER PACING FOR LV OUTFLOW OBSTRUCTION IN HYPERTROPHIC CARDIOMYOPATHY
-
批准号:3843408
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:L FANANAPAZIR
-
依托单位:
A-V NODE ABLATION IN HYPERTROPHIC CARDIOMYOPATHY
-
批准号:3843409
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:L FANANAPAZIR
-
依托单位:
HYPERTROPHIC CARDIOMYOPATHY
-
批准号:3779621
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:L FANANAPAZIR
-
依托单位: